nitrites has been researched along with palmidrol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baldi, A; Calabresi, P; Coppola, F; Mancini, ML; Pini, LA; Rossi, C; Sarchielli, P | 1 |
| Cinelli, MP; D'Amico, A; De Filippis, D; Di Marzo, V; Esposito, G; Iuvone, T | 1 |
| Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Navarra, M; Paterniti, I | 1 |
| Avagliano, C; Boatto, G; Calignano, A; Luongo, E; Magliocca, S; Meli, R; Melisi, D; Nieddu, M; Orefice, NS; Raso, GM; Rimoli, MG; Russo, R; Santiago, GM; Santoro, A | 1 |
| Campolo, M; Cordaro, M; Cornelius, C; Cuzzocrea, S; Esposito, E; Navarra, M; Paterniti, I; Siracusa, R | 1 |
| Ahmad, A; Bruschetta, G; Crupi, R; Cuzzocrea, S; Di Paola, R; Esposito, E; Impellizzeri, D; Paterniti, I; Prosdocimi, M; Siracusa, R | 1 |
6 other study(ies) available for nitrites and palmidrol
| Article | Year |
|---|---|
Endocannabinoids in chronic migraine: CSF findings suggest a system failure.
Topics: Adult; Amides; Arachidonic Acids; Calcitonin Gene-Related Peptide; Cannabinoid Receptor Modulators; Chromatography, High Pressure Liquid; Chronic Disease; Endocannabinoids; Ethanolamines; Female; Gas Chromatography-Mass Spectrometry; Glycerides; Headache Disorders, Secondary; Humans; Male; Migraine Disorders; Nitrites; Palmitic Acids; Polyunsaturated Alkamides; Surveys and Questionnaires | 2007 |
Adelmidrol, a palmitoylethanolamide analogue, reduces chronic inflammation in a carrageenin-granuloma model in rats.
Topics: Amides; Animals; Blotting, Western; Carrageenan; Cell Count; Chronic Disease; Dicarboxylic Acids; Dose-Response Relationship, Drug; Endocannabinoids; Ethanolamines; Granuloma; Inflammation; Leukocytes; Male; Mast Cells; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Nitrites; Palmitic Acids; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2009 |
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury.
Topics: Amides; Animals; Blotting, Western; Cell Survival; Coloring Agents; Cyclooxygenase 2; Drug Combinations; Endocannabinoids; Ethanolamines; Inflammation; Luteolin; Mice; Nanoparticles; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitrites; Organ Culture Techniques; Palmitic Acids; Pharmaceutical Solutions; Spinal Cord Injuries; Tetrazolium Salts; Thiazoles | 2013 |
Galactosyl prodrug of palmitoylethanolamide: synthesis, stability, cell permeation and cytoprotective activity.
Topics: Amides; Analgesics; Biological Transport; Cell Line, Tumor; Cell Survival; Cytoprotection; Drug Stability; Ethanolamines; Galactose; Humans; Hydrogen-Ion Concentration; Neuroprotective Agents; Nitrites; Oxidopamine; Palmitates; Palmitic Acids; Permeability; Prodrugs | 2014 |
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer's disease models: the control of neuroinflammation.
Topics: Amides; Amyloid beta-Peptides; Animals; Brain-Derived Neurotrophic Factor; Caspase 3; Cell Line, Tumor; DNA Damage; Dose-Response Relationship, Drug; Drug Interactions; Ethanolamines; Gene Expression Regulation; Glial Cell Line-Derived Neurotrophic Factor; Glial Fibrillary Acidic Protein; Hippocampus; Humans; I-kappa B Proteins; In Vitro Techniques; Luteolin; Mice; Neuroblastoma; Neuroprotective Agents; NF-kappa B; NF-KappaB Inhibitor alpha; Nitrites; Organ Culture Techniques; Palmitic Acids; Peptide Fragments | 2014 |
Effects of palmitoylethanolamide and silymarin combination treatment in an animal model of kidney ischemia and reperfusion.
Topics: Active Transport, Cell Nucleus; Amides; Animals; Apoptosis; Cell Nucleus; Chymases; Cytokines; Disease Models, Animal; Disease Progression; Drug Interactions; Ethanolamines; Gene Expression Regulation; Kidney; Male; Mice; Nitrates; Nitrites; Oxidative Stress; Palmitic Acids; Reperfusion Injury; Risk Factors; Silymarin; Transcription Factor RelA; Tyrosine | 2015 |